nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A1—liver cancer	0.418	1	CbGaD
Rabeprazole—ABCG2—Sorafenib—liver cancer	0.0805	0.268	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—liver cancer	0.0489	0.163	CbGbCtD
Rabeprazole—CYP2C19—Sorafenib—liver cancer	0.036	0.12	CbGbCtD
Rabeprazole—CYP1A2—Sorafenib—liver cancer	0.0332	0.111	CbGbCtD
Rabeprazole—CYP2C9—Sorafenib—liver cancer	0.0299	0.0996	CbGbCtD
Rabeprazole—CYP2D6—Sorafenib—liver cancer	0.0274	0.0911	CbGbCtD
Rabeprazole—CYP3A4—Sorafenib—liver cancer	0.0174	0.0579	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—liver cancer	0.0166	0.0553	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—liver cancer	0.0106	0.0351	CbGbCtD
Rabeprazole—Omeprazole—CYP1A1—liver cancer	0.000815	0.522	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A1—liver cancer	0.000745	0.478	CrCbGaD
Rabeprazole—Thrombophlebitis—Doxorubicin—liver cancer	0.00025	0.00132	CcSEcCtD
Rabeprazole—Increased appetite—Epirubicin—liver cancer	0.000249	0.00131	CcSEcCtD
Rabeprazole—Diabetes mellitus—Doxorubicin—liver cancer	0.000248	0.00131	CcSEcCtD
Rabeprazole—Hepatic function abnormal—Doxorubicin—liver cancer	0.000247	0.0013	CcSEcCtD
Rabeprazole—Urticaria—Sorafenib—liver cancer	0.000247	0.0013	CcSEcCtD
Rabeprazole—Photosensitivity—Doxorubicin—liver cancer	0.000246	0.0013	CcSEcCtD
Rabeprazole—Abdominal pain—Sorafenib—liver cancer	0.000246	0.00129	CcSEcCtD
Rabeprazole—Body temperature increased—Sorafenib—liver cancer	0.000246	0.00129	CcSEcCtD
Rabeprazole—Eye pain—Doxorubicin—liver cancer	0.000239	0.00126	CcSEcCtD
Rabeprazole—Hyponatraemia—Epirubicin—liver cancer	0.000234	0.00124	CcSEcCtD
Rabeprazole—Diplopia—Epirubicin—liver cancer	0.000234	0.00123	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000234	0.00123	CcSEcCtD
Rabeprazole—Osteoarthritis—Epirubicin—liver cancer	0.000234	0.00123	CcSEcCtD
Rabeprazole—Increased appetite—Doxorubicin—liver cancer	0.00023	0.00121	CcSEcCtD
Rabeprazole—Migraine—Epirubicin—liver cancer	0.00023	0.00121	CcSEcCtD
Rabeprazole—Hypersensitivity—Sorafenib—liver cancer	0.000229	0.00121	CcSEcCtD
Rabeprazole—Face oedema—Epirubicin—liver cancer	0.000225	0.00119	CcSEcCtD
Rabeprazole—Asthenia—Sorafenib—liver cancer	0.000223	0.00117	CcSEcCtD
Rabeprazole—Pruritus—Sorafenib—liver cancer	0.00022	0.00116	CcSEcCtD
Rabeprazole—Dehydration—Epirubicin—liver cancer	0.000217	0.00114	CcSEcCtD
Rabeprazole—Hyponatraemia—Doxorubicin—liver cancer	0.000217	0.00114	CcSEcCtD
Rabeprazole—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000216	0.00114	CcSEcCtD
Rabeprazole—Osteoarthritis—Doxorubicin—liver cancer	0.000216	0.00114	CcSEcCtD
Rabeprazole—Diplopia—Doxorubicin—liver cancer	0.000216	0.00114	CcSEcCtD
Rabeprazole—Liver function test abnormal—Epirubicin—liver cancer	0.000216	0.00114	CcSEcCtD
Rabeprazole—Dry skin—Epirubicin—liver cancer	0.000214	0.00113	CcSEcCtD
Rabeprazole—Abdominal pain upper—Epirubicin—liver cancer	0.000213	0.00112	CcSEcCtD
Rabeprazole—Migraine—Doxorubicin—liver cancer	0.000213	0.00112	CcSEcCtD
Rabeprazole—Hypokalaemia—Epirubicin—liver cancer	0.000213	0.00112	CcSEcCtD
Rabeprazole—Diarrhoea—Sorafenib—liver cancer	0.000213	0.00112	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00021	0.00111	CcSEcCtD
Rabeprazole—Face oedema—Doxorubicin—liver cancer	0.000209	0.0011	CcSEcCtD
Rabeprazole—Gastritis—Epirubicin—liver cancer	0.000207	0.00109	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000206	0.00109	CcSEcCtD
Rabeprazole—Dizziness—Sorafenib—liver cancer	0.000205	0.00108	CcSEcCtD
Rabeprazole—Abdominal distension—Epirubicin—liver cancer	0.000203	0.00107	CcSEcCtD
Rabeprazole—Asthma—Epirubicin—liver cancer	0.000202	0.00106	CcSEcCtD
Rabeprazole—Dysphagia—Epirubicin—liver cancer	0.000202	0.00106	CcSEcCtD
Rabeprazole—Dehydration—Doxorubicin—liver cancer	0.000201	0.00106	CcSEcCtD
Rabeprazole—Liver function test abnormal—Doxorubicin—liver cancer	0.0002	0.00105	CcSEcCtD
Rabeprazole—Dry skin—Doxorubicin—liver cancer	0.000198	0.00104	CcSEcCtD
Rabeprazole—Pancreatitis—Epirubicin—liver cancer	0.000198	0.00104	CcSEcCtD
Rabeprazole—Vomiting—Sorafenib—liver cancer	0.000197	0.00104	CcSEcCtD
Rabeprazole—Abdominal pain upper—Doxorubicin—liver cancer	0.000197	0.00104	CcSEcCtD
Rabeprazole—Hypokalaemia—Doxorubicin—liver cancer	0.000197	0.00104	CcSEcCtD
Rabeprazole—Angina pectoris—Epirubicin—liver cancer	0.000197	0.00104	CcSEcCtD
Rabeprazole—Rash—Sorafenib—liver cancer	0.000196	0.00103	CcSEcCtD
Rabeprazole—Dermatitis—Sorafenib—liver cancer	0.000196	0.00103	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000195	0.00103	CcSEcCtD
Rabeprazole—Headache—Sorafenib—liver cancer	0.000195	0.00103	CcSEcCtD
Rabeprazole—Bronchitis—Epirubicin—liver cancer	0.000194	0.00102	CcSEcCtD
Rabeprazole—Pancytopenia—Epirubicin—liver cancer	0.000192	0.00101	CcSEcCtD
Rabeprazole—Gastritis—Doxorubicin—liver cancer	0.000191	0.00101	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000191	0.001	CcSEcCtD
Rabeprazole—Dysuria—Epirubicin—liver cancer	0.000189	0.000995	CcSEcCtD
Rabeprazole—Neutropenia—Epirubicin—liver cancer	0.000189	0.000995	CcSEcCtD
Rabeprazole—Abdominal distension—Doxorubicin—liver cancer	0.000188	0.000991	CcSEcCtD
Rabeprazole—Dysphagia—Doxorubicin—liver cancer	0.000187	0.000984	CcSEcCtD
Rabeprazole—Asthma—Doxorubicin—liver cancer	0.000187	0.000984	CcSEcCtD
Rabeprazole—Pollakiuria—Epirubicin—liver cancer	0.000186	0.000983	CcSEcCtD
Rabeprazole—Nausea—Sorafenib—liver cancer	0.000184	0.000972	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Epirubicin—liver cancer	0.000184	0.000971	CcSEcCtD
Rabeprazole—Weight increased—Epirubicin—liver cancer	0.000184	0.000968	CcSEcCtD
Rabeprazole—Pancreatitis—Doxorubicin—liver cancer	0.000183	0.000965	CcSEcCtD
Rabeprazole—Weight decreased—Epirubicin—liver cancer	0.000183	0.000963	CcSEcCtD
Rabeprazole—Hyperglycaemia—Epirubicin—liver cancer	0.000182	0.00096	CcSEcCtD
Rabeprazole—Angina pectoris—Doxorubicin—liver cancer	0.000182	0.000959	CcSEcCtD
Rabeprazole—Pneumonia—Epirubicin—liver cancer	0.000181	0.000954	CcSEcCtD
Rabeprazole—Bronchitis—Doxorubicin—liver cancer	0.00018	0.000947	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000178	0.00094	CcSEcCtD
Rabeprazole—Pancytopenia—Doxorubicin—liver cancer	0.000177	0.000935	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Epirubicin—liver cancer	0.000176	0.00093	CcSEcCtD
Rabeprazole—Stomatitis—Epirubicin—liver cancer	0.000175	0.000925	CcSEcCtD
Rabeprazole—Jaundice—Epirubicin—liver cancer	0.000175	0.000925	CcSEcCtD
Rabeprazole—Conjunctivitis—Epirubicin—liver cancer	0.000175	0.000922	CcSEcCtD
Rabeprazole—Urinary tract infection—Epirubicin—liver cancer	0.000175	0.000922	CcSEcCtD
Rabeprazole—Dysuria—Doxorubicin—liver cancer	0.000175	0.000921	CcSEcCtD
Rabeprazole—Neutropenia—Doxorubicin—liver cancer	0.000175	0.000921	CcSEcCtD
Rabeprazole—Sweating—Epirubicin—liver cancer	0.000173	0.000909	CcSEcCtD
Rabeprazole—Pollakiuria—Doxorubicin—liver cancer	0.000173	0.000909	CcSEcCtD
Rabeprazole—Haematuria—Epirubicin—liver cancer	0.000172	0.000904	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—liver cancer	0.00017	0.000899	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—liver cancer	0.00017	0.000896	CcSEcCtD
Rabeprazole—Epistaxis—Epirubicin—liver cancer	0.00017	0.000895	CcSEcCtD
Rabeprazole—Weight decreased—Doxorubicin—liver cancer	0.000169	0.000891	CcSEcCtD
Rabeprazole—Sinusitis—Epirubicin—liver cancer	0.000169	0.00089	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—liver cancer	0.000168	0.000888	CcSEcCtD
Rabeprazole—Agranulocytosis—Epirubicin—liver cancer	0.000168	0.000885	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—liver cancer	0.000168	0.000883	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000165	0.00087	CcSEcCtD
Rabeprazole—Bradycardia—Epirubicin—liver cancer	0.000164	0.000867	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—liver cancer	0.000163	0.00086	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—liver cancer	0.000162	0.000856	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—liver cancer	0.000162	0.000856	CcSEcCtD
Rabeprazole—Rhinitis—Epirubicin—liver cancer	0.000162	0.000854	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—liver cancer	0.000162	0.000853	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—liver cancer	0.000162	0.000853	CcSEcCtD
Rabeprazole—Hepatitis—Epirubicin—liver cancer	0.000162	0.000852	CcSEcCtD
Rabeprazole—Pharyngitis—Epirubicin—liver cancer	0.00016	0.000845	CcSEcCtD
Rabeprazole—Sweating—Doxorubicin—liver cancer	0.00016	0.000841	CcSEcCtD
Rabeprazole—Urinary tract disorder—Epirubicin—liver cancer	0.00016	0.000841	CcSEcCtD
Rabeprazole—Oedema peripheral—Epirubicin—liver cancer	0.000159	0.000839	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—liver cancer	0.000159	0.000837	CcSEcCtD
Rabeprazole—Urethral disorder—Epirubicin—liver cancer	0.000158	0.000835	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—liver cancer	0.000157	0.000828	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—liver cancer	0.000156	0.000823	CcSEcCtD
Rabeprazole—Visual impairment—Epirubicin—liver cancer	0.000156	0.000821	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—liver cancer	0.000155	0.000819	CcSEcCtD
Rabeprazole—Erythema multiforme—Epirubicin—liver cancer	0.000153	0.000805	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—liver cancer	0.000152	0.000802	CcSEcCtD
Rabeprazole—Eye disorder—Epirubicin—liver cancer	0.000151	0.000796	CcSEcCtD
Rabeprazole—Tinnitus—Epirubicin—liver cancer	0.000151	0.000794	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—liver cancer	0.00015	0.00079	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—liver cancer	0.00015	0.000788	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—liver cancer	0.000148	0.000782	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—liver cancer	0.000148	0.000778	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—liver cancer	0.000147	0.000776	CcSEcCtD
Rabeprazole—Angiopathy—Epirubicin—liver cancer	0.000147	0.000773	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—liver cancer	0.000147	0.000772	CcSEcCtD
Rabeprazole—Chills—Epirubicin—liver cancer	0.000145	0.000764	CcSEcCtD
Rabeprazole—Arrhythmia—Epirubicin—liver cancer	0.000144	0.000761	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—liver cancer	0.000144	0.000759	CcSEcCtD
Rabeprazole—Alopecia—Epirubicin—liver cancer	0.000143	0.000753	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—liver cancer	0.000141	0.000745	CcSEcCtD
Rabeprazole—Erythema—Epirubicin—liver cancer	0.000141	0.000741	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—liver cancer	0.000141	0.000741	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—liver cancer	0.00014	0.000736	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—liver cancer	0.000139	0.000735	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—liver cancer	0.000139	0.00073	CcSEcCtD
Rabeprazole—Tension—Epirubicin—liver cancer	0.000138	0.000727	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—liver cancer	0.000138	0.000726	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—liver cancer	0.000137	0.00072	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—liver cancer	0.000136	0.000717	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—liver cancer	0.000136	0.000715	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—liver cancer	0.000135	0.000713	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—liver cancer	0.000134	0.000707	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—liver cancer	0.000134	0.000704	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—liver cancer	0.000133	0.000699	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—liver cancer	0.000132	0.000696	CcSEcCtD
Rabeprazole—Ill-defined disorder—Epirubicin—liver cancer	0.000131	0.000688	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—liver cancer	0.00013	0.000686	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—liver cancer	0.00013	0.000686	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—liver cancer	0.00013	0.000685	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—liver cancer	0.000129	0.000681	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—liver cancer	0.000128	0.000676	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—liver cancer	0.000128	0.000673	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—liver cancer	0.000127	0.000672	CcSEcCtD
Rabeprazole—Malaise—Epirubicin—liver cancer	0.000127	0.000669	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—liver cancer	0.000126	0.000666	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—liver cancer	0.000126	0.000666	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—liver cancer	0.000126	0.000665	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—liver cancer	0.000126	0.000664	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—liver cancer	0.000126	0.000663	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—liver cancer	0.000125	0.000659	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—liver cancer	0.000124	0.000655	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—liver cancer	0.000124	0.000652	CcSEcCtD
Rabeprazole—Cough—Epirubicin—liver cancer	0.000123	0.000647	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—liver cancer	0.000123	0.000646	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—liver cancer	0.000122	0.000642	CcSEcCtD
Rabeprazole—Hypertension—Epirubicin—liver cancer	0.000121	0.00064	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—liver cancer	0.000121	0.000636	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—liver cancer	0.00012	0.000634	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—liver cancer	0.00012	0.000631	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—liver cancer	0.00012	0.000631	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—liver cancer	0.00012	0.000631	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—liver cancer	0.00012	0.00063	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—liver cancer	0.000119	0.000629	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—liver cancer	0.000118	0.000624	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—liver cancer	0.000117	0.000619	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—liver cancer	0.000117	0.000617	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—liver cancer	0.000117	0.000616	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—liver cancer	0.000117	0.000615	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—liver cancer	0.000116	0.000614	CcSEcCtD
Rabeprazole—Confusional state—Epirubicin—liver cancer	0.000116	0.00061	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—liver cancer	0.000115	0.000606	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—liver cancer	0.000115	0.000605	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—liver cancer	0.000115	0.000605	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—liver cancer	0.000114	0.000603	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—liver cancer	0.000114	0.000599	CcSEcCtD
Rabeprazole—Shock—Epirubicin—liver cancer	0.000113	0.000595	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—liver cancer	0.000113	0.000594	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—liver cancer	0.000112	0.000592	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—liver cancer	0.000112	0.000592	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—liver cancer	0.000112	0.00059	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—liver cancer	0.000111	0.000585	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—liver cancer	0.000111	0.000584	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—liver cancer	0.000111	0.000584	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—liver cancer	0.000111	0.000584	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—liver cancer	0.00011	0.000582	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—liver cancer	0.000109	0.000577	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—liver cancer	0.000109	0.000577	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—liver cancer	0.000108	0.000571	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—liver cancer	0.000107	0.000565	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—liver cancer	0.000107	0.000564	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—liver cancer	0.000106	0.00056	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—liver cancer	0.000106	0.00056	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000105	0.000551	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—liver cancer	0.000104	0.000551	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—liver cancer	0.000104	0.000548	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—liver cancer	0.000104	0.000547	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—liver cancer	0.000104	0.000546	CcSEcCtD
Rabeprazole—Paraesthesia—Epirubicin—liver cancer	0.000103	0.000543	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—liver cancer	0.000103	0.000541	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—liver cancer	0.000102	0.000539	CcSEcCtD
Rabeprazole—Somnolence—Epirubicin—liver cancer	0.000102	0.000538	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—liver cancer	0.000101	0.000534	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—liver cancer	0.000101	0.000533	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—liver cancer	9.98e-05	0.000526	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—liver cancer	9.92e-05	0.000523	CcSEcCtD
Rabeprazole—Pain—Epirubicin—liver cancer	9.82e-05	0.000517	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—liver cancer	9.82e-05	0.000517	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—liver cancer	9.68e-05	0.00051	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—liver cancer	9.61e-05	0.000506	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—liver cancer	9.54e-05	0.000503	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—liver cancer	9.47e-05	0.000499	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—liver cancer	9.46e-05	0.000499	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—liver cancer	9.44e-05	0.000498	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—liver cancer	9.39e-05	0.000495	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—liver cancer	9.35e-05	0.000493	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—liver cancer	9.23e-05	0.000487	CcSEcCtD
Rabeprazole—Urticaria—Epirubicin—liver cancer	9.12e-05	0.000481	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—liver cancer	9.08e-05	0.000479	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—liver cancer	9.08e-05	0.000479	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—liver cancer	9.07e-05	0.000478	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—liver cancer	9.07e-05	0.000478	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—liver cancer	8.75e-05	0.000461	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—liver cancer	8.69e-05	0.000458	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—liver cancer	8.46e-05	0.000446	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—liver cancer	8.44e-05	0.000445	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—liver cancer	8.4e-05	0.000443	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—liver cancer	8.4e-05	0.000443	CcSEcCtD
Rabeprazole—Asthenia—Epirubicin—liver cancer	8.24e-05	0.000434	CcSEcCtD
Rabeprazole—Pruritus—Epirubicin—liver cancer	8.12e-05	0.000428	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—liver cancer	7.85e-05	0.000414	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—liver cancer	7.83e-05	0.000412	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—liver cancer	7.62e-05	0.000402	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—liver cancer	7.59e-05	0.0004	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—liver cancer	7.51e-05	0.000396	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—liver cancer	7.3e-05	0.000385	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—liver cancer	7.27e-05	0.000383	CcSEcCtD
Rabeprazole—Rash—Epirubicin—liver cancer	7.24e-05	0.000381	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—liver cancer	7.23e-05	0.000381	CcSEcCtD
Rabeprazole—Headache—Epirubicin—liver cancer	7.19e-05	0.000379	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—liver cancer	7.02e-05	0.00037	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—liver cancer	6.82e-05	0.000359	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—liver cancer	6.75e-05	0.000356	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—liver cancer	6.7e-05	0.000353	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—liver cancer	6.69e-05	0.000353	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—liver cancer	6.65e-05	0.000351	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—liver cancer	6.31e-05	0.000333	CcSEcCtD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	2.66e-05	0.000293	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—UGDH—liver cancer	2.65e-05	0.000292	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CPT1B—liver cancer	2.52e-05	0.000278	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GLUL—liver cancer	2.52e-05	0.000278	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—EPT1—liver cancer	2.49e-05	0.000275	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NR1H4—liver cancer	2.43e-05	0.000268	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—HPGDS—liver cancer	2.4e-05	0.000264	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTA3—liver cancer	2.39e-05	0.000263	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TAT—liver cancer	2.36e-05	0.00026	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	2.33e-05	0.000256	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.23e-05	0.000246	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTA4—liver cancer	2.19e-05	0.000241	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PSMA4—liver cancer	2.14e-05	0.000236	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PSMD10—liver cancer	2.14e-05	0.000236	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTA2—liver cancer	2.13e-05	0.000235	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GOT2—liver cancer	2.08e-05	0.000229	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CPT1B—liver cancer	2.06e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GLUL—liver cancer	2.06e-05	0.000227	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTA1—liver cancer	2.06e-05	0.000226	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—UGDH—liver cancer	2.05e-05	0.000226	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	2.04e-05	0.000225	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.04e-05	0.000224	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—NAT2—liver cancer	2.03e-05	0.000224	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NR1H4—liver cancer	1.99e-05	0.000219	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP2E1—liver cancer	1.96e-05	0.000215	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTA3—liver cancer	1.96e-05	0.000215	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.95e-05	0.000215	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALDOB—liver cancer	1.95e-05	0.000215	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—EPT1—liver cancer	1.93e-05	0.000212	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CPT1B—liver cancer	1.9e-05	0.000209	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GLUL—liver cancer	1.9e-05	0.000209	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CPT1B—liver cancer	1.88e-05	0.000207	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GLUL—liver cancer	1.88e-05	0.000207	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CRABP1—liver cancer	1.86e-05	0.000205	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	1.84e-05	0.000203	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYCS—liver cancer	1.83e-05	0.000202	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NR1H4—liver cancer	1.83e-05	0.000202	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TAT—liver cancer	1.83e-05	0.000201	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NR1H4—liver cancer	1.81e-05	0.0002	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTA3—liver cancer	1.8e-05	0.000198	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GOT1—liver cancer	1.8e-05	0.000198	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GGT1—liver cancer	1.8e-05	0.000198	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTA4—liver cancer	1.79e-05	0.000197	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTA3—liver cancer	1.78e-05	0.000196	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.75e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTA2—liver cancer	1.74e-05	0.000192	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.74e-05	0.000192	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTA1—liver cancer	1.68e-05	0.000185	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.67e-05	0.000184	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—NAT2—liver cancer	1.66e-05	0.000183	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTA4—liver cancer	1.65e-05	0.000181	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTA4—liver cancer	1.63e-05	0.00018	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HPGDS—liver cancer	1.62e-05	0.000179	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.62e-05	0.000178	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTP1—liver cancer	1.61e-05	0.000178	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CPT1B—liver cancer	1.61e-05	0.000177	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GLUL—liver cancer	1.61e-05	0.000177	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTA2—liver cancer	1.6e-05	0.000177	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.6e-05	0.000176	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALDOB—liver cancer	1.59e-05	0.000176	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.59e-05	0.000176	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—HMOX1—liver cancer	1.59e-05	0.000175	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTA2—liver cancer	1.59e-05	0.000175	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NR1H4—liver cancer	1.55e-05	0.000171	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTA1—liver cancer	1.55e-05	0.00017	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTA1—liver cancer	1.53e-05	0.000169	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—NAT2—liver cancer	1.53e-05	0.000168	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTA3—liver cancer	1.52e-05	0.000168	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CRABP1—liver cancer	1.52e-05	0.000168	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—NAT2—liver cancer	1.52e-05	0.000167	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTM1—liver cancer	1.48e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.47e-05	0.000162	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALDOB—liver cancer	1.47e-05	0.000162	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.46e-05	0.000161	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALDOB—liver cancer	1.45e-05	0.00016	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.45e-05	0.00016	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PSMA4—liver cancer	1.45e-05	0.000159	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PSMD10—liver cancer	1.45e-05	0.000159	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GOT2—liver cancer	1.41e-05	0.000155	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP1A1—liver cancer	1.41e-05	0.000155	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CRABP1—liver cancer	1.4e-05	0.000154	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTA4—liver cancer	1.39e-05	0.000154	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CRABP1—liver cancer	1.39e-05	0.000153	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.37e-05	0.000151	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.36e-05	0.00015	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTA2—liver cancer	1.36e-05	0.00015	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HPGDS—liver cancer	1.33e-05	0.000146	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYP2E1—liver cancer	1.32e-05	0.000146	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.32e-05	0.000146	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTA1—liver cancer	1.31e-05	0.000144	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—MTHFR—liver cancer	1.31e-05	0.000144	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—NAT2—liver cancer	1.3e-05	0.000143	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARA—liver cancer	1.29e-05	0.000142	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.28e-05	0.000141	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.25e-05	0.000138	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.25e-05	0.000137	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALDOB—liver cancer	1.24e-05	0.000137	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GLUL—liver cancer	1.24e-05	0.000137	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CPT1B—liver cancer	1.24e-05	0.000137	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CYCS—liver cancer	1.24e-05	0.000136	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HPGDS—liver cancer	1.22e-05	0.000135	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GGT1—liver cancer	1.22e-05	0.000134	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GOT1—liver cancer	1.22e-05	0.000134	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HPGDS—liver cancer	1.21e-05	0.000134	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.21e-05	0.000133	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.2e-05	0.000133	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NR1H4—liver cancer	1.2e-05	0.000132	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.19e-05	0.000131	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CRABP1—liver cancer	1.19e-05	0.000131	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PSMD10—liver cancer	1.18e-05	0.000131	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PSMA4—liver cancer	1.18e-05	0.000131	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA3—liver cancer	1.18e-05	0.00013	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GOT2—liver cancer	1.15e-05	0.000127	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CG—liver cancer	1.1e-05	0.000121	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.1e-05	0.000121	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTP1—liver cancer	1.09e-05	0.00012	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PSMA4—liver cancer	1.09e-05	0.00012	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PSMD10—liver cancer	1.09e-05	0.00012	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP2E1—liver cancer	1.08e-05	0.000119	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.08e-05	0.000119	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PSMA4—liver cancer	1.08e-05	0.000119	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PSMD10—liver cancer	1.08e-05	0.000119	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—HMOX1—liver cancer	1.08e-05	0.000119	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA4—liver cancer	1.08e-05	0.000118	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.07e-05	0.000118	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARG—liver cancer	1.06e-05	0.000117	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GOT2—liver cancer	1.06e-05	0.000117	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GOT2—liver cancer	1.05e-05	0.000116	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.05e-05	0.000116	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA2—liver cancer	1.05e-05	0.000115	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HPGDS—liver cancer	1.04e-05	0.000114	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.03e-05	0.000113	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYCS—liver cancer	1.01e-05	0.000112	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTA1—liver cancer	1.01e-05	0.000111	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—liver cancer	1e-05	0.000111	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—NAT2—liver cancer	1e-05	0.00011	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP2E1—liver cancer	9.97e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GGT1—liver cancer	9.95e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GOT1—liver cancer	9.95e-06	0.00011	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP2E1—liver cancer	9.88e-06	0.000109	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—liver cancer	9.68e-06	0.000107	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDOB—liver cancer	9.59e-06	0.000106	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.57e-06	0.000105	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ALB—liver cancer	9.55e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.38e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYCS—liver cancer	9.33e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.26e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYCS—liver cancer	9.25e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PSMA4—liver cancer	9.23e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PSMD10—liver cancer	9.23e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GOT1—liver cancer	9.15e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GGT1—liver cancer	9.15e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CRABP1—liver cancer	9.15e-06	0.000101	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GGT1—liver cancer	9.07e-06	9.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GOT1—liver cancer	9.07e-06	9.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GOT2—liver cancer	8.98e-06	9.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—liver cancer	8.94e-06	9.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—MTHFR—liver cancer	8.87e-06	9.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—HMOX1—liver cancer	8.81e-06	9.71e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARA—liver cancer	8.7e-06	9.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP2E1—liver cancer	8.44e-06	9.3e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—liver cancer	8.44e-06	9.29e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—liver cancer	8.22e-06	9.05e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—liver cancer	8.21e-06	9.05e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.18e-06	9.01e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—liver cancer	8.15e-06	8.98e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—HMOX1—liver cancer	8.11e-06	8.93e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—HMOX1—liver cancer	8.04e-06	8.85e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HPGDS—liver cancer	7.99e-06	8.81e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYCS—liver cancer	7.9e-06	8.7e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.82e-06	8.61e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A1—liver cancer	7.79e-06	8.58e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GGT1—liver cancer	7.75e-06	8.54e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GOT1—liver cancer	7.75e-06	8.54e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—liver cancer	7.55e-06	8.32e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—liver cancer	7.49e-06	8.25e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—liver cancer	7.45e-06	8.21e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—MTHFR—liver cancer	7.26e-06	8e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARG—liver cancer	7.19e-06	7.92e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A1—liver cancer	7.16e-06	7.89e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PSMA4—liver cancer	7.13e-06	7.85e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PSMD10—liver cancer	7.13e-06	7.85e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARA—liver cancer	7.12e-06	7.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A1—liver cancer	7.1e-06	7.82e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—liver cancer	6.96e-06	7.67e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GOT2—liver cancer	6.93e-06	7.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—HMOX1—liver cancer	6.87e-06	7.56e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—MTHFR—liver cancer	6.68e-06	7.35e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—MTHFR—liver cancer	6.62e-06	7.29e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—liver cancer	6.55e-06	7.22e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARA—liver cancer	6.55e-06	7.21e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP2E1—liver cancer	6.52e-06	7.18e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARA—liver cancer	6.49e-06	7.15e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALB—liver cancer	6.47e-06	7.12e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—liver cancer	6.4e-06	7.05e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.4e-06	7.05e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—liver cancer	6.1e-06	6.72e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYCS—liver cancer	6.1e-06	6.72e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1A1—liver cancer	6.07e-06	6.68e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GGT1—liver cancer	5.98e-06	6.59e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GOT1—liver cancer	5.98e-06	6.59e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARG—liver cancer	5.89e-06	6.48e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.83e-06	6.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—liver cancer	5.71e-06	6.29e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—MTHFR—liver cancer	5.66e-06	6.23e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—liver cancer	5.61e-06	6.18e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—liver cancer	5.56e-06	6.13e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARA—liver cancer	5.55e-06	6.11e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARG—liver cancer	5.41e-06	5.96e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—liver cancer	5.37e-06	5.92e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARG—liver cancer	5.37e-06	5.91e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—liver cancer	5.36e-06	5.91e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—HMOX1—liver cancer	5.3e-06	5.84e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALB—liver cancer	5.29e-06	5.83e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—liver cancer	5.14e-06	5.66e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.98e-06	5.49e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—liver cancer	4.94e-06	5.44e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—liver cancer	4.93e-06	5.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—liver cancer	4.89e-06	5.38e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALB—liver cancer	4.87e-06	5.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALB—liver cancer	4.83e-06	5.32e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—liver cancer	4.75e-06	5.23e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A1—liver cancer	4.68e-06	5.16e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—liver cancer	4.67e-06	5.15e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARG—liver cancer	4.59e-06	5.05e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—MTHFR—liver cancer	4.36e-06	4.81e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—liver cancer	4.3e-06	4.73e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARA—liver cancer	4.28e-06	4.72e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—liver cancer	4.26e-06	4.69e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—liver cancer	4.2e-06	4.63e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—liver cancer	4.18e-06	4.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALB—liver cancer	4.12e-06	4.54e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—liver cancer	3.67e-06	4.04e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—liver cancer	3.64e-06	4.01e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARG—liver cancer	3.54e-06	3.9e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—liver cancer	3.48e-06	3.83e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—liver cancer	3.22e-06	3.55e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALB—liver cancer	3.18e-06	3.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—liver cancer	2.85e-06	3.14e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—liver cancer	2.84e-06	3.13e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—liver cancer	2.81e-06	3.1e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—liver cancer	2.62e-06	2.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—liver cancer	2.6e-06	2.86e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—liver cancer	2.33e-06	2.56e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—liver cancer	2.22e-06	2.44e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—liver cancer	2.14e-06	2.36e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—liver cancer	2.12e-06	2.34e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—liver cancer	1.81e-06	2e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—liver cancer	1.71e-06	1.89e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—liver cancer	1.4e-06	1.54e-05	CbGpPWpGaD
